Senator has questions on Amgen anemia drug rebates

WASHINGTON (Reuters) – Sen. Charles Grassley asked Amgen Inc to explain why some doctors received higher rebates on purchases of the company’s anti-anemia drug Aranesp, a letter released on Thursday said.